Therefore, CNP-related immunofluorescence intensity was measured in ischemia-affected areas, thereby confirming a 2.2-fold increase in the ischemic cortex and a 3.6-fold increase as compared to contralateral control areas (Figures 2A, B and Supplementary Table 1). The gene discussed is CNP; the disease is ischemia.